A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct.
Atorvastatin calcium (ATV) is one of the most frequently prescribed drugs worldwide. Among the adverse effects observed for this lipid-lowering agent, clinical cases of cutaneous adverse reactions have been reported and associated with photosensitivity disorders. Previous work dealing with ATV photochemistry has shown that exposure to natural sunlight in aqueous solution leads to photoproducts resulting from oxidation of the pyrrole ring and from cyclization to a phenanthrene derivative. Laser flash photolysis of ATV, at both 266 and 308 nm, led to a transient spectrum with two maxima at lambda= 360 and lambda= 580 nm (tau= 41 micro), which was assigned to the primary intermediate of the stilbene-like photocyclization. On the basis of the absence of a triplet-triplet absorption, the role of the parent drug as singlet oxygen photosensitizer can be discarded. By contrast, a stable phenanthrene-like photoproduct would be a good candidate to play this role. Laser flash photolysis of this compound showed a triplet-triplet transient absorption at lambdamax = 460 nm with a lifetime of 26 micro, which was efficiently quenched by oxygen (kq = 3 (+/-0.2) x 10(9) M(-1) s(-1)). Its potential to photosensitize formation of singlet oxygen was confirmed by spin trapping experiments, through conversion of TEMP to the stable free radical TEMPO. The photoreactivity of the phenanthrene-like photoproduct was investigated using Trp as a marker. The disappearance of the amino acid fluorescence (lambdamax = 340 nm) after increasing irradiation times at 355 nm was taken as a measurement of photodynamic oxidation. To confirm the involvement of a type II mechanism, the same experiment was also performed in D2O; this resulted in a significant enhancement of the reaction rate. On the basis of the obtained photophysical and photochemical results, the phototoxicity of atorvastatin can be attributed to singlet oxygen formation with the phenanthrene-like photoproduct as a photosensitizer.
Montanaro
Sara
S
Instituto de Tecnologia Quimica, UPV-CSIC, UniVersidad Polité cnica de Valencia, AVenida de Los Naranjos, s/n, 46022, Valencia, Spain.
Lhiaubet-Vallet
Virginie
V
Iesce
MariaRosaria Iesce
MI
Previtera
Lucio
L
Miranda
Miguel Angel
MA
D000069059:Atorvastatin; D003500:Cyclization; D004578:Electron Spin Resonance Spectroscopy; D006538:Heptanoic Acids / Q000737:chemistry* / Q000528:radiation effects / Q000633:toxicity*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000737:chemistry* / Q000528:radiation effects / Q000633:toxicity*; D010616:Phenanthrenes / Q000737:chemistry; D011758:Pyrroles / Q000737:chemistry* / Q000528:radiation effects / Q000633:toxicity*; D026082:Singlet Oxygen / Q000737:chemistry*; D014364:Tryptophan / Q000737:chemistry
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010616:Phenanthrenes; D011758:Pyrroles; D026082:Singlet Oxygen; D014364:Tryptophan; D000069059:Atorvastatin